Evidence map›Paper›PMID 33188300›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

Biallelic variants in HPDL, encoding 4-hydroxyphenylpyruvate dioxygenase-like protein, lead to an infantile neurodegenerative condition.

Shereen G Ghosh, Sangmoon Lee, Rudy Fabunan, Guoliang Chai, Maha S Zaki, Ghada Abdel-Salam, Tipu Sultan, Tawfeg Ben-Omran, Javeria Raza Alvi, Jennifer McEvoy-Venneri and 20 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05848271 (A Patient Registry and Natural History Study of Patients with Biallelic HPDL Mutations), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05848271 recruitingnot on this mapstarted 2023, after this paper: background citation

A Patient Registry and Natural History Study of Patients with Biallelic HPDL Mutations

TypeobservationalSponsorUniversity of California, San DiegoRan2023 to 2027Enrolled50ConditionsMitochondrial Encephalomyopathies, Hereditary Spastic Paraplegia, Spastic Paraplegia, White Matter DiseaseArmsPatient Registry, Dry blood spots sampling
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. HPDL Variant Type Correlates With Clinical Disease Onset and Severity.Annals of clinical and translational neurology · 2025
    Observational
  7. Quantitative natural history modeling of HPDL-related disease based on cross-sectional data reveals genotype-phenotype correlations.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Functional genomics and small molecules in mitochondrial neurodevelopmental disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  15. Article
  16. Article
  17. Neuroimaging in Primary Coenzyme-QAntioxidants (Basel, Switzerland) · 2023
    Review
  18. The Human Glyoxalase Gene Family in Health and Disease.Chemical research in toxicology · 2022
    Review
  19. Article
  20. Case Report: Two Families WithFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 10 institutions in 7 countries.

Shereen G Ghosh *Department of Neurosciences, University of California-San Diego, La Jolla, CA, USA.
Sangmoon Lee *Department of Neurosciences, University of California-San Diego, La Jolla, CA, USA.
Rudy FabunanBiology Department, San Diego State University, San Diego, CA, USA.
Guoliang ChaiDepartment of Neurosciences, University of California-San Diego, La Jolla, CA, USA.
Maha S ZakiClinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt.
Ghada Abdel-SalamClinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt.
Tipu SultanDepartment of Pediatric Neurology, Institute of Child Health, Children Hospital Lahore, Lahore, Pakistan.
Tawfeg Ben-OmranDivision of Genetic and Genomic Medicine, Sidra Medicine and Hamad Medical Corporation, Doha, Qatar.
Javeria Raza AlviDepartment of Pediatric Neurology, Institute of Child Health, Children Hospital Lahore, Lahore, Pakistan.
Jennifer McEvoy-VenneriDepartment of Neurosciences, University of California-San Diego, La Jolla, CA, USA.
Valentina StanleyDepartment of Neurosciences, University of California-San Diego, La Jolla, CA, USA.
Aakash PatelDepartment of Neurosciences, University of California-San Diego, La Jolla, CA, USA.
Danica RossDepartment of Neurosciences, University of California-San Diego, La Jolla, CA, USA.
Jeffrey DingDepartments of Medicine and Pharmacology, University of California-San Diego, La Jolla, CA, USA.
Mohit JainDepartments of Medicine and Pharmacology, University of California-San Diego, La Jolla, CA, USA.
Daqiang PanCentre for Integrative Signalling Analysis (CISA), University of Freiburg, Freiburg, Germany.
Philipp LübbertInstitute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bernd KammererCentre for Integrative Signalling Analysis (CISA), University of Freiburg, Freiburg, Germany.
Nils WiedemannInstitute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Nanda M Verhoeven-DuifSection Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Judith J JansSection Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
David MurphyDepartment of Clinical and Movement Neurosciences, UCL Institute of Neurology, Queen Square, London, UK.
Mehran Beiraghi ToosiPediatric Neurology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Farah AshrafzadehDepartment of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Shima ImannezhadDepartment of Pediatric Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ehsan Ghayoor KarimianiMolecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London, UK.
Khalid IbrahimDivision of Pediatric Neurology, Sidra Medicine, Doha, Qatar.
Elizabeth R WatersBiology Department, San Diego State University, San Diego, CA, USA.
Reza MaroofianGenetics Research Centre, Molecular and Clinical Sciences Institute, St. George's University, London, UK.
Joseph G GleesonDepartment of Neurosciences, University of California-San Diego, La Jolla, CA, USA. jogleeson@health.ucsd.edu.ORCID http://orcid.org/0000-0002-0889-9220
Children’s Institute · USUniversity of Freiburg · DEMashhad University of Medical Sciences · IRNational Research Centre · EGSan Diego State University · USSt George's, University of London · GBUniversity Medical Center Utrecht · NLUniversity of California San Diego · USHamad Medical Corporation · QANational Hospital for Neurology and Neurosurgery · GB

Funding

Large Scale Sequencing and Analysis of GenomesU54HG003067 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY, LANDER, ERIC S · 2004 to 2015
$568.6M
Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
Yale Center for Mendelian DisordersU54HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2012 to 2015
$11.0M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Training Program in Basic Clinical GeneticsT32GM008666 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMILTON, BRUCE A · 1998 to 2021
$8.6M
Molecular Characterization of Joubert SyndromeR01NS048453 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G · 2004 to 2020
$6.0M
Mosaicism in focal cortical dysplasias spectrum seen in neuropsychiatric diseaseU01MH108898 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G · 2015 to 2019
$5.1M
Molecular Characterization of Pontocerebellar HypoplasiaR01NS098004 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOSEPH G GLEESON · 2016 to 2026
$4.6M
Mapping the Plasma Exposome and its Association with Human Cardiovascular DiseaseR01ES027595 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAIN, MOHIT · 2017 to 2021
$3.3M
RapidFire mass spectrometry systemS10OD020025 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAIN, MOHIT · 2015 to 2015
$600k
Molecular mechanisms of the ADPRHL2-mediated pediatric neurodegenerative diseaseF31HD095602 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, SHEREEN G. · 2018 to 2020
$116k
Department of HealthNHGRI NIH HHS U54 HG003067NHGRI NIH HHS U54 HG006504NHGRI NIH HHS UM1 HG008900NICHD NIH HHS F31 HD095602NIEHS NIH HHS R01 ES027595NIGMS NIH HHS T32 GM008666NIH HHS S10OD020025NIH HHS U01 MH108898NINDS NIH HHS P30 NS047101NINDS NIH HHS R01 NS048453NINDS NIH HHS R01 NS098004
6 · The paper itself

Abstract

purposeDioxygenases are oxidoreductase enzymes with roles in metabolic pathways necessary for aerobic life. 4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL), encoded by HPDL, is an orphan paralogue of 4-hydroxyphenylpyruvate dioxygenase (HPD), an iron-dependent dioxygenase involved in tyrosine catabolism. The function and association of HPDL with human diseases remain unknown.

methodsWe applied exome sequencing in a cohort of over 10,000 individuals with neurodevelopmental diseases. Effects of HPDL loss were investigated in vitro and in vivo, and through mass spectrometry analysis. Evolutionary analysis was performed to investigate the potential functional separation of HPDL from HPD.

resultsWe identified biallelic variants in HPDL in eight families displaying recessive inheritance. Knockout mice closely phenocopied humans and showed evidence of apoptosis in multiple cellular lineages within the cerebral cortex. HPDL is a single-exonic gene that likely arose from a retrotransposition event at the base of the tetrapod lineage, and unlike HPD, HPDL is mitochondria-localized. Metabolic profiling of HPDL mutant cells and mice showed no evidence of altered tyrosine metabolites, but rather notable accumulations in other metabolic pathways.

conclusionThe mitochondrial localization, along with its disrupted metabolic profile, suggests HPDL loss in humans links to a unique neurometabolic mitochondrial infantile neurodegenerative condition.

Indexed as

4-Hydroxyphenylpyruvate DioxygenaseDioxygenasesAnimalsExonsHumansMiceMice, KnockoutPhenotype4-Hydroxyphenylpyruvate DioxygenaseDioxygenases4-hydroxyphenylpyruvate dioxygenase-like proteinHPDHPDLneurodegenerative diseaseoxidoreductase

Identifiers

PMID33188300
OpenAlexW3101857905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.